Mercury Laboratories Limited Share Price

₹ 760.05

+0.00 (0.00%)
1D
Last updated 02 Nov, 2026, 13:35 IST
BSE: 538964
|
Pharmaceuticals
Share price over the last 1 day fell from 790.00 to 760.05, ranging between 760.05 and 829.80.
--
0.00% up today
--
1D LOW
1D HIGH

Mercury Laboratories Limited Stock Insights

Stock Performance
OutperformingBeat Nifty by 3.42 % in last 1 month
Mercury Laboratories Limited stock performance
Open--
High--
Low--
Prev. close₹760.05
Mercury Laboratories Limited trading activity
Volume--
Average traded price--
Last traded time01:35:47 02 Nov
Last traded quantity1
Circuit
L
H
₹608.05
₹912.05
52-week
L
H
₹620.55
₹928.50
Mkt Cap Cr
94.80
P/E
21.9
P/B
1.57
ROA
5.27%
ROE
8.32%
ROCE
10.75%
Quick Ratio
3.24
EV/EBITDA
10.42

Based on fundamentals, this stock's

Performance: 2 out of 5, Poor
Performance
Poor
Mercury Labs has underperformed the market
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Mercury Labs appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,24,202.4238.614.759.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7390.3115.7614.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,23,685.4926.934.568.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,11,868.0340.542.884.79%7.21%8.58%1.3519.05
Cipla1,11,647.7239.123.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,951.1826.132.566.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Mercury Laboratories Limited Company Background

ISIN
INE947G01011
Sector Market Cap
₹ 94.80 Cr

Mercury Laboratories Limited is an India-based pharmaceutical company. The Company operates through the Pharmaceuticals Products segment. It is engaged in the manufacturing and export of a range of pharmaceutical items. The products of the Company are in the segment of gynecology and pediatrics. Its products include antibiotic, antifungal, and antiviral formulations; anti-inflammatory formulations; antimalarial formulations; digestive formulations; hypoglycemic formulations; multivitamin formulations; central nervous system formulations; gynec formulations; CVS formulations; cough and cold formulations; and miscellaneous formulations, and innovative products. Its antibiotic, antifungal, and antiviral formulations include azithromycin tablets, azithromycin dispersible tablets, griseofulvin tablets, metronidazole tablets, and others. Its anti-inflammatory formulations include dexamethasone tablets, glucosamine sulphate tablets, dexamethasone sodium phosphate injection, and others.

Mercury Laboratories Limited Financial Highlights

  • Revenue: Mercury Laboratories Limited reported revenue of ₹77.90 crore in FY26 vs ₹76.17 crore in FY25. It showed an increase of 2.27% on a yearly basis.
  • Operating Profit: Mercury Laboratories Limited reported an operating profit of ₹6.64 crore in FY26 vs ₹4.66 crore in FY25. It showed an increase of 42.49% on a year-on-year basis.
  • Net Profit: Mercury Laboratories Limited reported a net profit of ₹4.83 crore in FY26 vs ₹3.14 crore in FY25. It showed an increase of 53.82% on a yearly basis.

Mercury Laboratories Limited Quarterly Result Highlights

  • Mercury Laboratories Limited reported revenue of ₹16.01 crore in Jun 2026, compared with ₹21.11 crore in Mar 2026, representing a decrease of 24.16% on a quarter-on-quarter (QoQ) basis.
  • Mercury Laboratories Limited reported an operating profit of ₹0.39 crore in Jun 2026, compared with ₹1.74 crore in Mar 2026, representing a decrease of 77.59% on a quarter-on-quarter (QoQ) basis.
  • Mercury Laboratories Limited reported a profit of ₹0.30 crore in Jun 2026, compared with ₹1.23 crore in Mar 2026, reflecting a decrease of 75.61% on a QoQ basis.
  • The earnings per share (EPS) of Mercury Laboratories Limited stood at ₹40.28 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
73.66%
FII
0.00%
Other DII
0.00%
Retail and other
26.34%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

Mercury Laboratories Limited Investment Returns

1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--

Mercury Laboratories Limited Share Price History

Mercury Laboratories Limited share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹897.95 / ₹760.05
-3.79%
30 Oct 26
₹790.00 / ₹790.00
+7.63%
29 Oct 26
₹733.00 / ₹734.00
-2.13%
27 Oct 26
₹735.00 / ₹749.95
+2.16%
Show more

Mercury Laboratories Limited Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹75.94₹75.10₹75.56₹75.33
Other Income₹1.96₹1.07₹1.09₹1.72
Total Revenue₹77.89₹76.17₹76.65₹77.05
Total Expenses₹70.86₹71.51₹69.73₹69.61
Profit Before Tax₹6.64₹4.66₹6.92₹7.44
Tax₹1.80₹1.52₹1.27₹1.87
Profit After Tax₹4.83₹3.14₹5.65₹5.58
EPS - Basic₹40.28₹26.21₹47.12₹46.49
EPS - Diluted₹40.28₹26.21₹47.12₹46.49

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹6.64₹4.66₹6.92₹7.44
Income before WC changes₹10.60₹8.14₹10.12₹10.29
Change in Assets-₹2.01-₹4.91₹0.40-₹6.11
Change in Liabilities-₹3.09₹4.03-₹1.04-₹0.63
Change in WC-₹5.11-₹0.89-₹0.64-₹6.73
Cash flow from Operations₹4.24₹4.86₹8.23₹2.45
Cash flow from Investing-₹3.17-₹9.04-₹6.27-₹1.06
Cash flow from Financing₹2.91-₹1.85-₹1.04-₹1.01
Total Cash Flow₹3.99-₹6.03₹0.91₹0.38
Cash (Start of the year)₹2.19₹8.23₹7.32₹6.93
Cash (End of the year)₹6.18₹2.19₹8.23₹7.32

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹34.14₹35.01₹28.12₹24.71
Current Assets₹44.95₹39.22₹39.84₹39.46
Total Assets₹79.08₹74.24₹67.96₹64.16
Current Liabilities₹11.69₹15.08₹12.63₹14.18
Net Current Asset₹33.26₹24.15₹27.20₹25.28
Non-Current Liabilities₹9.32₹5.59₹4.49₹4.36
Equity Capital₹58.08₹53.57₹50.84₹45.63
Total Equity & Liabilities₹79.08₹74.24₹67.96₹64.16
* All values are in INR Crore
Mercury Laboratories Limited market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
Mercury Laboratories Limited technical summary
Bearish indicators2
Neutral indicators2
Bullish indicators4
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
49.59
Neutral
ATR (14)
30.19
Bearish
STOCH(9,6)
17.89
Bullish
STOCH RSI (14)
60.26
Neutral
ADX(9)
26.94
Bearish
UO(9)
26.87
Bullish
ROC(12)
0.67
Bullish
WillR(14)
-82.11
Bullish
Period
Simple value
Exponential vaue
5D
753.62
757.4
10D
746.98
754.08
20D
755.09
758.19
50D
770.13
769.84
100D
784.66
772.59
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Mercury Laboratories Limited
Pharmaceuticals
Add Stock
Add Another

Mercury Laboratories Limited Returns Calculator

Ex-date: 21 Sep 2026

Top Gainers

KRBL Share Price
₹401.45
+38.45 (+10.59%)
MARICO Share Price
₹878.40
+79.85 (+10%)
BALRAMCHIN Share Price
₹654.80
+54.9 (+9.15%)
TRIDENT Share Price
₹23.79
+1.58 (+7.11%)
AEGISLOG Share Price
₹1177.10
+77 (+7%)
See more

Top Losers

KEC Share Price
₹316.35
-32.65 (-9.36%)
GNFC Share Price
₹465.05
-45.95 (-8.99%)
PRAJIND Share Price
₹254.63
-16.5 (-6.09%)
AIAENG Share Price
₹3389.70
-217.6 (-6.03%)
GESHIP Share Price
₹1536.50
-63.9 (-3.99%)
See more

Mercury Laboratories Limited Share Price FAQs

Please be aware that Mercury Laboratories Limited stock prices are subject to continuous fluctuations due to various factors.